Community
India’s Sun Pharma posts lower quarterly profit on one-time acquisition-related charge
By Jenna Larson
AstraZeneca kicks off savings drive to invest in pipeline after sales beat
Tommy Anderson
Tommy Anderson
Reporter · Fargo, ND
Tommy Anderson is a community reporter with a knack for uncovering local stories that matter. He has a journalism degree from Minnesota State University Moorhead and has reported for several local news organizations over his eight-year career.
More from Tommy →Reporter · Friday, October 30, 2026 at 7:07 AM · 1 min read
Oct 30 (Reuters) AstraZeneca on Friday announced a restructuring programme aimed at supporting pipeline investments with benefits of about $1.5 billion to keep the drugmaker on track to achieve its target of generating $80 billion in annual revenue by 2030. The moves were announced alongside third-quarter results, which surpassed analyst expectations. (Reporting by Pushkala Aripaka, Sri Hari N S in Bengaluru and Patrick Wingrove in London; Editing by Janane Venkatraman)
Up nextIndia’s Sun Pharma posts lower quarterly profit on one-time acquisition-related chargeCommunity · 1 min read
